Rhotekin Inhibitors
The chemicals listed above target various aspects of the Rho GTPase signaling cascade, which is intricately connected to the function of Rhotekin. By inhibiting RhoA, for example, Rhosin could reduce the activation of Rhotekin, which binds to active RhoA. ROCK inhibitors like Y-27632 and Fasudil could impact the downstream effects of Rhotekin on actin cytoskeleton organization.
The relationship between these chemicals and their indirect inhibition of Rhotekin relies on the complex network of signaling pathways involved in cytoskeletal dynamics. These pathways are critical for the regulation of cell morphology and motility, processes in which Rhotekin has an established role. The inhibitors might modulate the activity of Rhotekin by preventing its activation or by altering the cytoskeletal structures it helps to control. The specific outcomes of such inhibition would depend on the cellular context and the presence of other regulatory factors. The indirect modulation of Rhotekin by these chemicals offers potential insights into the broader role of Rho GTPases and their associated effectors in cellular dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
A selective inhibitor of Rho GTPase that binds to RhoA and prevents its activation, potentially affecting Rhotekin's interactions. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
A Rho/MKL1 pathway inhibitor that could reduce transcriptional responses downstream of RhoA and Rhotekin. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Another ROCK inhibitor that could impact actin cytoskeleton organization and thus indirectly influence Rhotekin. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A selective inhibitor of Cdc42 GTPase, which may indirectly affect Rhotekin activity through alteration of the cytoskeleton. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
Cdc42 activity-specific inhibitor that could alter the downstream effects of Rhotekin by changing Cdc42 activity. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
A Cdc42 GTPase inhibitor that might disrupt the interaction between Cdc42 and its effectors, such as Rhotekin. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
An inhibitor of Trio, a guanine nucleotide exchange factor for Rac and RhoG, which could affect Rhotekin's pathway. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
A Rac1 inhibitor that could indirectly modulate the signaling pathways involving Rhotekin. | ||||||